We would love to hear your thoughts about our site and services, please take our survey here.
I think you will find that opinion is synonymous with view @Standonkin01
It's a way to make money but I certainly wouldn't want to rely on it to make a living! If you have a company that you have confidence in ie that the current SP underestimates the true value of what the market will value it down the line, you can "comfortably" trade the volatility knowing that if you get a trade "wrong" time will eventually eradicate the mistake as events unfold.
This is of course a form of gambling but you are skewing the odds in your favour with a company like Avacta.
Of course, you can be knocked out by a curve ball like the failure of the LFT so no-one should ever gamble more than they are comfortably able to lose.
If, for example, you consider that gold and other precious metals are likely to represent good hedges against inflation you can trade certain precious metals stocks in a similar way. It's about what works for you.
A no brainer top up opportunity for the well researched now!
If Wyndrum bores you Tim just ignore or filter him. He has a trading strategy and uses a system that he believes in and that appears to work for him (but not every trade will be successful obviously).
What I find boring and unacceptable is the constant denigration and abuse. He may well be "up himself" but that could be levelled at many more on here.
For those of us that have a core holding but also have a trading pot that exploits the volatility, his views are useful and I hope that the bully boys don't achieve their aim to stop him posting. Q follow up abuse from the usual suspects.
Companies with great medium to long term prospects that have volatile SPs represent compelling short term trading opportunities. Not sure why anyone finds this upsetting.
Please continue to post your TA insights for those on here that don't have closed minds Wyndrum.
I personally think that AS wants to see this through himself. I really don't think that his prime motivation is making a financial killing. I think that he does want Avacta to be the next Roche.
This doesn't stop Big Pharma from making a move of course but I hope it stays independent and the UK develops another mega company that sees the tech through to its ultimate and successful conclusion.
As Agent B has pointed out, a takeover by Big Pharma could be detrimental to humanity rather than the positive that others assume.
Would have expected a much higher spike on such great news, especially with biopsy info. I guess the market must have anticipated the news in the recent run up towards 140p. I really did think that we would see Mr. R's £2 so this still has to be a bargain at this level. Have topped up on the pullback to 159p.
Buy before the Yanks wake up!
If there's a BO bid in the offing, for the whole or part of Avacta that's causing the reporting delay, wouldn't this be likely to scupper the Science Day as well?
Are you suggesting that US investors can't buy international shares on a US bank holiday Tim?
I can buy US shares via an online broker on Boxing Day, for example.
It will be interesting to see how the market would respond to a "no news" week next week. Would optimism over the results of the trial maintain the SP at the top of the present range or not? Just idle speculation on my part Wyndrum because I am expecting news even if it is just an explanation for the delay in reporting. I guess TA doesn't really help in this situation but, If there's no news would you be inclined to sell part of your stake to protect capital?
Have to agree with Darknightmy. It's about credibility and trust and the perception that the CEO doesn't have this aspect under control. This will tend to affect sentiment in the company going forward. I think we should either have the promised update next week or an explanation for the missed timeline in the alternative. Silence would, in my opinion, be treating shareholders with contempt.
You can always ask the doctor to stick two fingers up and get a second opinion! Sorry, Bob Monkhouse joke (who sadly died from prostate cancer)
But surely an update on progress of phase 1a, as promised for early January in the last RNS, has no relevance to the ongoing trial as far as reporting is concerned.
It seems that some are trying to manufacture excuses for the CEO. However I personally don't regard him as missing his self imposed timeline, as yet. A failure to provide the update this week would constitute a miss as far as I am concerned.
Thought that was to bale out Goldman Sachs Agent B
https://www.share-talk.com/share-talk-christmas-digest-ggp-held-gwmo-boil-angs-harl-prem-avct-maru-alk-gcat-kod-crcl-all-fcm/
Happy Christmas everyone.
Prof
CB is the P.T. Barnum of AIM and I am one of the suckers born every minute. Just contemplating a last top up before 12.30. A shrewd investment or good money after bad? Oh well, only time will tell. Let's hope for good things in 2023. Happy Christmas all.
Big Pharma have deep pockets. If they want it then I imagine they'll get it. More likely would be a bidding war for the Therapeutics division perhaps? Hope it stays in British hands whatever the future holds.
Hi BITL,
I am in the fortunate position of having a trading pot and my average is now below £1.
"Expectation" would have been a better word to use than "Fear" on reflection.
I consider that this share is my best chance of making serious money in the market at the moment.
I would only consider selling if the SP fell 25% from the current level. If it continues to drift down then I will continue to top up on a pound cost averaging basis.
A falling SP does however make the company more vulnerable to a hostile TO at an undervalued market cap as frustrated shareholders are tempted to sell and move on.